NCT00065169

Data

{
  "briefSummary": "The purpose of this study is to determine whether the anti-inflammatory drug celecoxib can delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment (AAMI). This study will also evaluate genetic risk and brain structure as potential predictors of mental decline.",
  "completionDate": "2005-11",
  "conditions": [
    "Alzheimer Disease",
    "Dementia"
  ],
  "enrollmentCount": 138,
  "enrollmentType": null,
  "nctId": "NCT00065169",
  "phase": "NA",
  "sponsorId": "university-of-california-los-angeles",
  "startDate": "2000-11",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Anti-Inflammation in AD: PET Imaging Supplement",
  "url": "https://clinicaltrials.gov/study/NCT00065169"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version